Реклама:
VIMRx Pharmaceuticals Inc. halted development of synthetic hypericin (VIMRxyn) for treatment of HIV-infection, chronic hepatitis C and sterilization of blood for transfusion ( www.bioinfo.com/aabrev98.html).